Research graph
References from Liquid biopsy in head and neck tumors: novel approaches and clinical applications. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 · External reference
Global burden of head and neck cancer: Epidemiological transitions, inequities, and projections to 2050
10.3389/fonc.2025.1665019 · 2025 · External reference
Rare Head and Neck Cancers and Pathological Diagnosis Challenges: A Comprehensive Literature Review
2024 · External reference
Prognostic implications across histological subtypes of head and neck squamous cell carcinoma: An update
10.1016/j.jormas.2024.102149 · 2025 · External reference
Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives. Frontiers
2024 · External reference
Rising incidence of late-stage head and neck cancer in the United States
10.1002/cncr.32583 · 2020 · External reference
Beyond tissue: Liquid biopsy’s promise in unmasking oral cancer
10.1016/j.oor.2024.100162 · 2024 · External reference
Head-to-Head Comparison of [18F]FDG PET Imaging and MRI for the Detection of Recurrence or Residual Tumor in Patients with Nasopharyngeal Carcinoma: A Meta-Analysis
10.3390/cancers16173011 · 2024 · External reference
Liquid biopsy in cancer: current status, challenges and future prospects
10.1038/s41392-024-02021-w · 2024 · External reference
Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
2024 · External reference
Novel Approaches and Future Directions
10.3390/cancers15051579 · 2023 · External reference
Leveraging Saliva for Insights into Head and Neck Cancer
10.3390/ijms252413514 · 2024 · External reference
The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine
2024 · External reference
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
10.3390/ijms24032505 · 2023 · External reference
Liquid biopsy technologies for hematological diseases
10.1002/med.21731 · 2021 · External reference
Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy
10.1007/s12094-026-04334-4 · 2026 · External reference
Circulating tumor cells as promising novel biomarkers in solid cancers
10.3109/10408363.2014.896316 · 2014 · External reference
Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
10.3390/cancers12092361 · 2020 · External reference
Recent Advances in Methods for Circulating Tumor Cell Detection
10.3390/ijms24043902 · 2023 · External reference
Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility
10.3390/ijms232113582 · 2022 · External reference
Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
10.3390/cancers15072051 · 2023 · External reference
The Role of Circulating Tumor DNA (ctDNA) in the Treatment of Human Papilloma Virus-positive (HPV+) Oropharyngeal Squamous Cell Carcinoma
10.1097/ppo.0000000000000769 · 2025 · External reference
Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma
10.1038/s41416-022-01716-7 · 2022 · External reference
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma
10.1158/1078-0432.ccr-24-0590 · 2024 · External reference
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer. npj Precision
10.1101/2025.01.27.25321198 · 2025 · External reference
Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review
10.1016/j.ctrv.2025.103070 · 2026 · External reference
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
10.1038/s41591-020-0933-1 · 2020 · External reference
Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
10.1186/s13148-019-0650-0 · 2019 · External reference
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients
2000 · External reference
Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer
10.1016/j.ejca.2018.08.013 · 2018 · External reference
Pre- and Post-operative Circulating Tumoral DNA in Patients With Medullary Thyroid Carcinoma
10.1210/clinem/dgac222 · 2022 · External reference
Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers
10.3390/cancers16132462 · 2024 · External reference
Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
10.1186/s41232-024-00358-x · 2024 · External reference
Extracellular vesicles as a promising biomarker resource in liquid biopsy for cancer
2021 · External reference
Salivary Extracellular Vesicles in Detection of Head and Neck Cancers: A Systematic Review
10.2147/ijn.s520288 · 2025 · External reference
Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors
10.3390/cancers15041307 · 2023 · External reference
RNA-Based Liquid Biopsy in Head and Neck Cancer
10.3390/cells12141916 · 2023 · External reference
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies
10.21037/tcr-20-2530 · 2021 · External reference
Non-coding RNAs-mediated regulation of the MAPK pathway in gastric cancer: translational perspectives
10.1007/s12672-025-03843-y · 2025 · External reference
Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma
10.1007/s12032-014-0148-8 · 2014 · External reference
Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis
10.3390/ijms22137026 · 2021 · External reference
MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy
10.21873/cgp.20119 · 2019 · External reference
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma
10.1002/hed.21713 · 2012 · External reference
Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
10.1177/1010428319826853 · 2019 · External reference
Long noncoding RNAs in head and neck cancer
10.18632/oncotarget.12960 · 2017 · External reference
Liquid Biopsy’s Role in Head and Neck Tumors: Changing Paradigms in the Era of Precision Medicine
10.3390/diagnostics15172262 · 2025 · External reference
Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC
10.1038/s41598-020-70747-y · 2020 · External reference
CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis
10.1042/cs20190110 · 2019 · External reference
A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma
10.1038/s41598-023-28550-y · 2023 · External reference
Lessons to learn from tumor-educated platelets
10.1182/blood.2019003976 · 2021 · External reference
Tumor-educated platelets
10.1182/blood-2018-12-852830 · 2019 · External reference
Platelets favor the outgrowth of established metastases
10.1038/s41467-024-47516-w · 2024 · External reference
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
10.1016/j.ccell.2015.09.018 · 2015 · External reference
Tumor-educated platelets in cancer diagnostics and prognostics: A critical appraisal and roadmap for clinical translation
10.1002/ijc.70423 · 2026 · External reference
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
10.1093/clinchem/hvaa103 · 2020 · External reference
Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
10.3390/ijms19102877 · 2018 · External reference
Saliva vs Plasma in Liquid Biopsy Sampling for Head and Neck Cancer: A Comparative Study
10.1093/clinchem/hvag035 · 2026 · External reference
Comparison of saliva and blood derived cell free RNAs for detecting oral squamous cell carcinoma
10.1038/s41598-025-88472-9 · 2025 · External reference
Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas
10.1371/journal.pone.0256979 · 2021 · External reference
Saliva as a Diagnostic Tool for Systemic Diseases-A
2025 · External reference
Characterization of non-invasive oropharyngeal samples and nucleic acid isolation for molecular diagnostics
10.1038/s41598-024-54179-6 · 2024 · External reference
Integrated analysis of oral rinse-derived and plasma circulating tumour DNA for mutation profiling and outcome prediction with oral squamous cell carcinoma
10.1038/s41698-025-00976-9 · 2025 · External reference
Diagnostic accuracy of HPV DNA in oral gargle and rinse samples for Head and neck squamous cell carcinoma: A systematic review and meta-analysis
10.1016/j.jdsr.2026.05.001 · 2026 · External reference
Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic?
10.3389/fonc.2022.828434 · 2022 · External reference
Urine as a Source of Liquid Biopsy for Cancer
10.3390/cancers13112652 · 2021 · External reference
Unlocking the potential of urine-based liquid biopsy through improved reporting and standardization
10.1038/s41568-025-00882-z · 2026 · External reference
Clinical applications of cerebrospinal fluid liquid biopsies in central nervous system tumors
10.1016/j.tranon.2024.101881 · 2024 · External reference
ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer
10.3390/cancers13091989 · 2021 · External reference
Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges
10.3390/cancers13081874 · 2021 · External reference
Potential use of liquid biopsy in diagnosing oral malignancies
10.6026/973206300213465 · 2025 · External reference
Challenges in circulating tumor cell detection by the CellSearch system
10.1016/j.molonc.2015.12.002 · 2016 · External reference
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
10.1038/bjc.2013.92 · 2013 · External reference
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
10.1073/pnas.1012539107 · 2010 · External reference
Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device
10.1371/journal.pone.0035976 · 2012 · External reference
S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells
10.3390/cells8070755 · 2019 · External reference
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications
10.1016/j.ccell.2025.07.008 · 2025 · External reference
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(®) PC1 System
10.3390/cancers14215238 · 2022 · External reference
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
10.1038/s41467-024-55140-x · 2025 · External reference
Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis
10.1063/1.4774304 · 2013 · External reference
A comparison of microfluidic methods for high-throughput cell deformability measurements
10.1038/s41592-020-0818-8 · 2020 · External reference
Acoustic separation of circulating tumor cells
10.1073/pnas.1504484112 · 2015 · External reference
Circulating tumor cells: biology and clinical significance
10.1038/s41392-021-00817-8 · 2021 · External reference
Single-cell analysis of circulating tumour cells: enabling technologies and clinical applications
10.1016/j.tibtech.2022.02.004 · 2022 · External reference
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
10.5772/60725 · 2015 · External reference
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
10.1016/j.ejca.2021.02.042 · 2021 · External reference
Application of exosomes as liquid biopsy in clinical diagnosis
10.1038/s41392-020-00258-9 · 2020 · External reference
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
10.1186/s40364-023-00540-2 · 2023 · External reference
Comparative study of size exclusion chromatography for isolation of small extracellular vesicle from cell-conditioned media, plasma, urine, and saliva
10.3389/fnano.2023.1146772 · 2023 · External reference
Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance
10.1016/j.jmoldx.2020.01.016 · 2020 · External reference
Extracellular Vesicles in Liquid Biopsies: Potential for Disease Diagnosis
10.1155/2021/6611244 · 2021 · External reference
Comparison of the efficiency of ultrafiltration, precipitation, and ultracentrifugation methods for exosome isolation
2024 · External reference
Advances in single extracellular vesicle characterization and multiplexed profiling
10.1016/j.trac.2025.118588 · 2026 · External reference
Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management
2023 · External reference
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets
10.1016/j.ccell.2017.07.004 · 2017 · External reference
Circulating Tumor DNA detection in cancer: a comprehensive overview of current detection methods and prospects
10.1093/oncolo/oyaf204 · 2025 · External reference
Clinical validation of a multiplex droplet digital PCR for diagnosing suspected bloodstream infections in ICU practice: a promising diagnostic tool
10.1186/s13054-022-04116-8 · 2022 · External reference
Absolute enumeration of probiotic strains Lactobacillus acidophilus NCFM® and Bifidobacterium animalis subsp. lactis Bl-04® via chip-based digital PCR
10.3389/fmicb.2018.00704 · 2018 · External reference
Circulating tumor DNA analysis for tumor diagnosis
10.1016/j.talanta.2021.122220 · 2021 · External reference
Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?
10.1515/cclm-2021-0171 · 2021 · External reference
Performance Comparison of Droplet Digital PCR and Next-Generation Sequencing for Circulating Tumor DNA Detection in Non-Metastatic Rectal Cancer
10.1002/cam4.70943 · 2025 · External reference
Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma
10.3390/ijms26020861 · 2025 · External reference
Diagnostic accuracy of next-generation sequencing (NGS) for identifying actionable mutations in advanced non-small cell lung cancer: Systematic Review and Meta-Analysis
10.1007/s12094-025-04040-7 · 2026 · External reference
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
10.18632/oncotarget.5788 · 2015 · External reference
From haystack to high precision: advanced sequencing methods to unraveling circulating tumor DNA mutations
10.3389/fmolb.2024.1423470 · 2024 · External reference
Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology. npj Precision
2025 · External reference
Real-World Technical Hurdles of ctDNA NGS Analysis: Lessons from Clinical Implementation
10.3390/diseases13100312 · 2025 · External reference
A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response
10.12659/msm.949300 · 2025 · External reference
Circular RNA-based liquid biopsy: a promising approach for monitoring drug resistance in cancer
2025 · External reference
An ultrasensitive method for detection of cell-free RNA
10.1038/s41586-025-08834-1 · 2025 · External reference
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
10.1186/s12943-022-01710-w · 2023 · External reference
Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatment
10.1016/j.ejca.2025.115626 · 2025 · External reference
Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer
10.1001/jamaoto.2023.1937 · 2023 · External reference
Study of the survival of patients with head and neck cancer in relation to Circulating Tumor Cells (CTCs)
10.1371/journal.pone.0320485 · 2025 · External reference
A Phase II Trial of Neoadjuvant Albumin-Bound Paclitaxel plus Carboplatin Combined with Tislelizumab in Locally Advanced HNSCC: Efficacy and Biomarker Exploration
10.1158/1078-0432.ccr-25-2911 · 2026 · External reference
Determination of PD-L1 Expression in Circulating Tumor Cells of Hypopharyngeal and Laryngeal Cancers and Correlation with Tissue Detection
10.2174/0118715206340244250605061005 · 2026 · External reference
Exosomal MicroRNAs as novel diagnostic biomarkers in head and neck cancer: a systematic evaluation and meta-analysis
10.1007/s00405-025-09643-y · 2025 · External reference
FTIR-based spectrum of salivary exosomes coupled with computational-aided discriminating analysis in the diagnosis of oral cancer
10.1007/s00432-018-02827-6 · 2019 · External reference
Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT
10.1080/2162402x.2019.1593805 · 2019 · External reference
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)
2024 · External reference
Diagnosis of head and neck cancer by AI-based tumor-educated platelet RNA profiling of liquid biopsies. JCI
2026 · External reference
Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
10.1186/s12885-015-1218-9 · 2015 · External reference
CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC
10.1186/s12860-024-00500-0 · 2024 · External reference
Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy
10.1111/1759-7714.12771 · 2018 · External reference
Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma
10.1186/s12885-018-4364-z · 2018 · External reference
Cross validated serum small extracellular vesicle microRNAs for the detection of oropharyngeal squamous cell carcinoma
10.1186/s12967-020-02446-1 · 2020 · External reference
Machine learning-driven identification of exosome- related biomarkers in head and neck squamous cell carcinoma
2025 · External reference
Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers
10.18632/oncotarget.19614 · 2017 · External reference
Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections
10.1002/ijc.31967 · 2019 · External reference
Small extracellular vesicle CA1 as a promising diagnostic biomarker for nasopharyngeal carcinoma
2024 · External reference
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening
10.1016/j.biopha.2019.109553 · 2020 · External reference
Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients
10.1111/jop.13263 · 2022 · External reference
Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma
10.1111/cas.15067 · 2021 · External reference
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
10.1007/s40618-023-02115-2 · 2023 · External reference
miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma
10.1111/cas.14883 · 2021 · External reference
Exploring salivary exosomes as early predictors of oral cancer in susceptible tobacco consumers: noninvasive diagnostic and prognostic applications
10.1007/s00432-023-05343-4 · 2023 · External reference
Development a glycosylated extracellular vesicle-derived miRNA Signature for early detection of esophageal squamous cell carcinoma
10.1186/s12916-025-03871-z · 2025 · External reference
Tumor-educated platelet SNORA58, SNORA68 and SNORD93 as novel diagnostic biomarkers for esophageal cancer
10.2217/fon-2023-0129 · 2023 · External reference
Circulating Tumor Cells in Head and Neck Squamous-Cell Carcinoma Exhibit Distinct Properties Based on Targeted Epithelial-Related Markers
10.3390/cimb47040240 · 2025 · External reference
Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients
10.1007/s00018-024-05269-1 · 2024 · External reference
The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)
10.1093/annonc/mdr130 · 2011 · External reference
Circulating hybrid cells predict presence of occult nodal metastases in oral cavity carcinoma
10.1002/hed.26692 · 2021 · External reference
Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
10.1186/s12885-023-11565-z · 2023 · External reference
Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report
10.3748/wjg.v21.i25.7921 · 2015 · External reference
Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma
10.1016/j.clinsp.2023.100179 · 2023 · External reference
Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma
10.1177/1533033820909911 · 2020 · External reference
Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review
10.1080/0284186x.2020.1742930 · 2020 · External reference
Comparative Analysis of TP53-Mutated Tumor DNA in Saliva and Plasma of Patients with Head and Neck Squamous Cell Carcinoma
10.1016/j.jmoldx.2025.10.002 · 2026 · External reference
The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis
10.1186/s12885-024-13116-6 · 2024 · External reference
The role of ctDNA from liquid biopsy in predicting survival outcomes in HPV-negative head and neck cancer: A meta-analysis
10.1016/j.oraloncology.2024.107148 · 2025 · External reference
Diagnostic and prognostic potential of salivary microRNA in oral and head and neck squamous cell carcinomas: a systematic review
10.1016/j.ijom.2026.01.004 · 2026 · External reference
Prognostic Implications of Exosomal miRNA Networks Regulating TGFβ1-induced Epithelial-Mesenchymal Transition Signature in Oral Squamous Cell Carcinoma
10.21873/cgp.20560 · 2026 · External reference
Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma
10.2147/ijn.s440684 · 2024 · External reference
Cancer-derived fucosylated exosomal miR-6842-3p as a novel marker promotes ESCC angiogenesis and metastasis via the PTEN/AKT/mTOR/IRF1/CXCL10 axis
10.1038/s41388-025-03643-2 · 2026 · External reference
Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology
10.1002/hed.24519 · 2016 · External reference
Circulating tumor cell abundance in head and neck squamous cell carcinoma decreases with successful chemoradiation and cetuximab treatment
10.1016/j.canlet.2023.216187 · 2023 · External reference
Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer
10.3390/ijms241310673 · 2023 · External reference
Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patients
10.1038/s41598-026-43178-4 · 2026 · External reference
Circulating exosome-derived miR-191-5p is a novel therapeutic biomarker for radiotherapy in esophageal squamous cell carcinoma patients
10.1007/s10388-025-01116-9 · 2025 · External reference
Emerging Proximal Liquid Biopsy Approaches for Detecting Residual Disease and Predicting Recurrence in Head and Neck Cancer: A Review and Proposal of Novel Liquid Staging
10.1002/hed.28138 · 2025 · External reference
Epithelial–Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma
10.21873/anticanres.14345 · 2020 · External reference
Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma
10.1002/hed.27167 · 2022 · External reference
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patients. npj Precision
2026 · External reference
ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer
10.1172/jci.insight.177759 · 2024 · External reference
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study
10.1016/j.ccell.2024.07.001 · 2024 · External reference
Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck
10.1038/s41418-024-01272-y · 2024 · External reference
Personalized cell-free tumor DNA analysis for patients with HNSCC: Liquid biopsy for minimal residual disease detection in head and neck squamous cell carcinoma (LIONESS)
10.1200/jco.2024.42.16_suppl.3010 · 2024 · External reference
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)
10.1016/j.ijrobp.2025.09.044 · 2026 · External reference
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
10.18632/oncotarget.8943 · 2016 · External reference
Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma
10.1016/j.oraloncology.2020.104631 · 2020 · External reference
Carcinoma-associated fibroblast-derived exosomes lncRNA RORA-AS1 facilitates radiotherapy resistance of oral squamous cell carcinoma through the IFITM1/STAT axis
10.1016/j.bbamcr.2025.120015 · 2025 · External reference
Circulating tumor DNA in Non-Viral head and neck squamous cell Carcinoma: A systematic review and Meta-Analysis
10.1016/j.oraloncology.2025.107760 · 2025 · External reference
The landscape of circulating tumor HPV DNA and TTMV-HPVDNA for surveillance of HPV-oropharyngeal carcinoma: systematic review and meta-analysis
10.1186/s13046-024-03137-1 · 2024 · External reference
Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis
10.1038/srep20210 · 2016 · External reference
Diagnostic and prognostic potential of cell-free RNAs in cerebrospinal fluid and plasma for brain tumors. npj Precision
2025 · External reference
Blood-based screening for HPV-associated cancers
2024 · External reference
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation
10.1158/1078-0432.ccr-23-3321 · 2024 · External reference
False-Positive Liquid Biopsy Assays Secondary to Overlapping Aberrant Methylation from Non-Cancer Disease States
10.1159/000535174 · 2023 · External reference
Ultra-Sensitive Mutation Detection Technology in Myeloid Neoplasms: New Tools for Patient Monitoring
10.3390/jcm15030998 · 2026 · External reference
Digital sequencing is improved by using structured unique molecular identifiers
10.1186/s13059-025-03504-x · 2025 · External reference
Duplex Proximity Sequencing (Pro-Seq): A method to improve DNA sequencing accuracy without the cost of molecular barcoding redundancy
10.1371/journal.pone.0204265 · 2018 · External reference
Multi-modal liquid biopsy integrating cfDNA fragmentomics and serum biomarkers for the differential diagnosis of ovarian tumors
10.1200/jco.2026.44.16_suppl.5573 · 2026 · External reference
Integrating liquid biopsy and mutational signatures to advance precision oncology. npj Precision
2026 · External reference
Liquid Biopsies in Head and Neck Cancers: Recent Developments Across Biofluids, Analytes, and Molecular Features
10.1002/hed.70009 · 2025 · External reference
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer
2023 · External reference
The pre-analytical phase of the liquid biopsy
10.1016/j.nbt.2019.09.006 · 2020 · External reference
Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling
10.1093/clinchem/hvad194 · 2024 · External reference
International liquid biopsy standardization alliance white paper
10.1016/j.critrevonc.2020.103112 · 2020 · External reference
Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis
10.1080/10408363.2023.2230290 · 2023 · External reference
